Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 6 studies | 30% ± 14% | |
| GABAergic neuron | 4 studies | 35% ± 14% | |
| interneuron | 4 studies | 31% ± 16% | |
| retinal cone cell | 3 studies | 27% ± 6% | |
| ciliated cell | 3 studies | 20% ± 5% | |
| glutamatergic neuron | 3 studies | 46% ± 12% | |
| enteroendocrine cell | 3 studies | 27% ± 12% | |
| astrocyte | 3 studies | 19% ± 2% | |
| neuron | 3 studies | 33% ± 7% | |
| oligodendrocyte | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 31% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 808.17 | 2639 / 2642 | 96% | 22.05 | 674 / 705 |
| thymus | 100% | 540.84 | 651 / 653 | 67% | 5.28 | 405 / 605 |
| breast | 92% | 226.10 | 420 / 459 | 73% | 5.62 | 820 / 1118 |
| pancreas | 99% | 477.46 | 325 / 328 | 54% | 3.82 | 97 / 178 |
| intestine | 95% | 327.49 | 915 / 966 | 38% | 1.66 | 201 / 527 |
| prostate | 80% | 144.32 | 195 / 245 | 41% | 1.92 | 206 / 502 |
| ovary | 98% | 472.52 | 177 / 180 | 19% | 0.90 | 83 / 430 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.52 | 1 / 1 |
| lung | 58% | 110.12 | 337 / 578 | 41% | 2.60 | 479 / 1155 |
| adrenal gland | 26% | 42.03 | 68 / 258 | 70% | 8.64 | 162 / 230 |
| uterus | 68% | 127.71 | 116 / 170 | 21% | 1.31 | 97 / 459 |
| kidney | 52% | 70.61 | 46 / 89 | 34% | 1.51 | 303 / 901 |
| esophagus | 60% | 236.93 | 867 / 1445 | 25% | 1.63 | 45 / 183 |
| heart | 83% | 275.80 | 715 / 861 | 0% | 0 | 0 / 0 |
| spleen | 74% | 122.79 | 178 / 241 | 0% | 0 | 0 / 0 |
| bladder | 48% | 56.10 | 10 / 21 | 26% | 1.61 | 129 / 504 |
| liver | 50% | 85.20 | 113 / 226 | 17% | 0.86 | 69 / 406 |
| stomach | 36% | 43.52 | 128 / 359 | 28% | 1.46 | 81 / 286 |
| blood vessel | 60% | 112.35 | 804 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 54% | 83.57 | 651 / 1204 | 0% | 0 | 0 / 0 |
| skin | 18% | 22.60 | 317 / 1809 | 13% | 0.64 | 59 / 472 |
| peripheral blood | 16% | 63.03 | 151 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 16% | 0.58 | 7 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.16 | 1 / 29 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.12 | 2 / 80 |
| muscle | 1% | 0.68 | 6 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
| GO_0007352 | Biological process | zygotic specification of dorsal/ventral axis |
| GO_0016055 | Biological process | Wnt signaling pathway |
| GO_0031410 | Cellular component | cytoplasmic vesicle |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0030165 | Molecular function | PDZ domain binding |
| GO_0008327 | Molecular function | methyl-CpG binding |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | CXXC4 |
| Protein name | CXXC-type zinc finger protein 4 (Inhibition of the Dvl and axin complex protein) CXXC-type zinc finger protein 4 |
| Synonyms | IDAX |
| Description | FUNCTION: Acts as a negative regulator of the Wnt signaling pathway via its interaction with DVL1 (By similarity). Binds preferentially to DNA containing cytidine-phosphate-guanosine (CpG) dinucleotides over CpH (H=A, T, and C), hemimethylated-CpG and hemimethylated-hydroxymethyl-CpG . . |
| Accessions | J9JIF5 Q9H2H0 ENST00000394767.3 A0A8V8TLX0 ENST00000698535.1 |
